We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
MasTec
MTZ
$26.7B
| $450K | ﹤0.01% |
9,191
-10,500
| -53% | -$468K |
|
|
RNET
1802
DELISTED
RigNet, Inc.
RNET
| $450K | ﹤0.01% |
30,074
-9,500
| -24% | -$154K |
|
|
CETV
1803
DELISTED
Central European Media Enterprises Ltd
CETV
| $450K | ﹤0.01% |
96,697
+40,600
| +72% | +$186K |
|
|
OTIC
1804
DELISTED
Otonomy, Inc.
OTIC
| $449K | ﹤0.01% |
80,900
-56,300
| -41% | -$244K |
|
|
IMDZ
1805
DELISTED
Immune Design Corp.
IMDZ
| $449K | ﹤0.01% |
+115,000
| New | +$626K |
|
1806
UMB Financial
UMBF
$10.7B
| $447K | ﹤0.01% |
6,218
-1,100
| -15% | -$80.8K |
|
|
SWIR
1807
DELISTED
Sierra Wireless
SWIR
| $447K | ﹤0.01% |
21,848
-4,700
| -18% | -$100K |
|
|
ZNH
1808
DELISTED
China Southern Airlines Company Limited
ZNH
| $446K | ﹤0.01% |
8,600
-1,500
| -15% | -$62.4K |
|
1809
Healthcare Services Group
HCSG
$1.56B
| $445K | ﹤0.01% |
+8,448
| New | +$443K |
|
|
BELFB
1810
Bel Fuse Inc Class B
BELFB
$3.88B
| $443K | ﹤0.01% |
17,613
-1,100
| -6% | -$31.5K |
|
1811
Advanced Drainage Systems
WMS
$10.9B
| $442K | ﹤0.01% |
+18,547
| New | +$399K |
|
1812
Arrow Financial
AROW
$652M
| $438K | ﹤0.01% |
15,389
-1,346
| -8% | -$39.7K |
|
1813
Camden Property Trust
CPT
$11.3B
| $437K | ﹤0.01% |
4,752
-62,100
| -93% | -$5.74M |
|
1814
Fate Therapeutics
FATE
$281M
| $436K | ﹤0.01% |
71,400
+51,400
| +257% | +$229K |
|
1815
Flexsteel Industries
FLXS
$306M
| $435K | ﹤0.01% |
9,300
| – | – |
|
1816
RBB Bancorp
RBB
$446M
| $435K | ﹤0.01% |
+15,900
| New | +$394K |
|
|
RPT
1817
Rithm Property Trust
RPT
$90.5M
| $435K | ﹤0.01% |
5,434
+1,164
| +27% | +$96.1K |
|
1818
InterContinental Hotels
IHG
$23B
| $433K | ﹤0.01% |
6,481
-11,263
| -63% | -$679K |
|
|
ARC
1819
DELISTED
ARC Document Solutions, Inc.
ARC
| $430K | ﹤0.01% |
168,760
+74,400
| +79% | +$245K |
|
|
MOFG
1820
DELISTED
MidWestOne Financial Group
MOFG
| $429K | ﹤0.01% |
12,800
+400
| +3% | +$14.1K |
|
1821
Ceco Environmental
CECO
$4.42B
| $426K | ﹤0.01% |
83,059
+41,437
| +100% | +$279K |
|
|
FBNK
1822
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $426K | ﹤0.01% |
16,298
+300
| +2% | +$7.94K |
|
1823
Agilysys
AGYS
$2.78B
| $424K | ﹤0.01% |
+34,566
| New | +$423K |
|
1824
Sempra
SRE
$60.8B
| $424K | ﹤0.01% |
7,928
-36,200
| -82% | -$2.1M |
|
1825
W&T Offshore
WTI
$545M
| $424K | ﹤0.01% |
128,200
+67,585
| +111% | +$210K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.